Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases
Saeedeh Ghorbanalipoor(University of Veterinary Medicine Vienna), Ralf J. Ludwig(University of Lübeck), Katharina Boch(University of Lübeck), Ibrahim O. Ibrahim(University of Lübeck), Melissa Parker(Incyte (United States)), Shirin Emtenani(University of Lübeck), Diana D. J. Wortmann(University of Lübeck), Mayumi Kamaguchi(University of Lübeck), Stanislav Khil’chenko(University of Lübeck), Paul A. Smith(Incyte (United States)), Natalie Groß(University of Lübeck), Manuela Pigors(University of Lübeck), Colin Osterloh(University of Lübeck), Katja Bieber(University of Lübeck), Stephanie Goletz(University of Lübeck), Enno Schmidt(Carrier (United States)), Sabrina Patzelt(University of Lübeck), Kathrin Kalies(University of Lübeck), Kentaro Izumi(University of Lübeck), Anika Kasprick(University of Lübeck)
Cited by 9
Related Papers
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation
|Journal of Clinical Investigation|2014|717
Psoriasis: a possible risk factor for development of coronary artery calcification
|British Journal of Dermatology|2006|376
Diagnosis and management of pemphigus: Recommendations of an international panel of experts
|Journal of the American Academy of Dermatology|2018|373
Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts
|Journal of the American Academy of Dermatology|2011|370
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)
|Journal of the European Academy of Dermatology and Venereology|2020|332